
Intuitive Surgical (ISRG) Stock Forecast & Price Target
Intuitive Surgical (ISRG) Analyst Ratings
Bulls say
Intuitive Surgical is in a strong position as the global market leader in robotic-assisted minimally invasive surgery, with over 11,000 da Vinci systems installed worldwide. The company's advancements in technology and increasing adoption in emerging markets and ASCs present compelling growth opportunities, and recent survey results show little sign of erosion in Intuitive's dominant competitive position. While there may be short-term challenges in the U.S. and OUS markets, the long-term outlook for Intuitive Surgical remains positive.
Bears say
Intuitive Surgical is the clear leader in the underpenetrated robotic surgery market with a dominant position in the US with over 6,600 installations. However, competition is growing and could erode its market share in the long run. With the rise of COVID-19 and potential disruptions to the healthcare system, there may be delays in new product adoption and procedural volume declines, posing risks to the company's future growth.
This aggregate rating is based on analysts' research of Intuitive Surgical and is not a guaranteed prediction by Public.com or investment advice.
Intuitive Surgical (ISRG) Analyst Forecast & Price Prediction
Start investing in Intuitive Surgical (ISRG)
Order type
Buy in
Order amount
Est. shares
0 shares